- Home
- AQST vs PDLB Comparison
AQST vs PDLB Comparison
Compare AQST & PDLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- PDLB
- Stock Information
- Founded
- AQST 2004
- PDLB 1960
- Country
- AQST United States
- PDLB United States
- Employees
- AQST N/A
- PDLB N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- PDLB
- Sector
- AQST Health Care
- PDLB
- Exchange
- AQST Nasdaq
- PDLB Nasdaq
- Market Cap
- AQST 224.9M
- PDLB 221.7M
- IPO Year
- AQST 2018
- PDLB 2017
- Fundamental
- Price
- AQST $4.18
- PDLB $10.84
- Analyst Decision
- AQST Strong Buy
- PDLB
- Analyst Count
- AQST 7
- PDLB 0
- Target Price
- AQST $8.57
- PDLB N/A
- AVG Volume (30 Days)
- AQST 1.2M
- PDLB 89.5K
- Earning Date
- AQST 08-06-2024
- PDLB 10-28-2024
- Dividend Yield
- AQST N/A
- PDLB N/A
- EPS Growth
- AQST N/A
- PDLB N/A
- EPS
- AQST N/A
- PDLB 0.39
- Revenue
- AQST $58,360,000.00
- PDLB $81,737,000.00
- Revenue This Year
- AQST $16.97
- PDLB N/A
- Revenue Next Year
- AQST N/A
- PDLB $7.70
- P/E Ratio
- AQST N/A
- PDLB $28.00
- Revenue Growth
- AQST 25.45
- PDLB 70.84
- 52 Week Low
- AQST $1.25
- PDLB $7.31
- 52 Week High
- AQST $6.23
- PDLB $11.34
- Technical
- Relative Strength Index (RSI)
- AQST 53.88
- PDLB 55.73
- Support Level
- AQST $4.13
- PDLB $10.97
- Resistance Level
- AQST $4.58
- PDLB $11.15
- Average True Range (ATR)
- AQST 0.27
- PDLB 0.21
- MACD
- AQST -0.06
- PDLB -0.05
- Stochastic Oscillator
- AQST 22.39
- PDLB 15.25
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
About PDLB Ponce Financial Group Inc.
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.